منابع مشابه
Lnc-ing Common Polymorphisms to Statin Responsiveness at the MYLIP Locus.
Metabolic Characterization of a Rare Genetic Variation Within APOC3 and Its Lipoprotein Lipase– Independent Effects Fotios Drenos, PhD; George Davey Smith, MD, DSc; Mika Ala-Korpela, PhD; Johannes Kettunen, PhD; Peter Würtz, PhD; Pasi Soininen, PhD; Antti J. Kangas, MSc; Caroline Dale, PhD; Debbie A. Lawlor, MBChB, PhD; Tom R. Gaunt, PhD; Juan-Pablo Casas, PhD; Nicholas J. Timpson, PhD . . . . ...
متن کاملLong-range enhancers on 8q24 regulate c-Myc.
Recent genomewide association studies have found multiple genetic variants on chromosome 8q24 that are significantly associated with an increased susceptibility to prostate, colorectal, and breast cancer. These risk loci are located in a "gene desert," a few hundred kilobases telomeric to the Myc gene. To date, the biological mechanism(s) underlying these associations remain unclear. It has bee...
متن کاملMAX-ing out MYC: a novel small molecule inhibitor against MYC-dependent tumors.
The Myc oncogene features prominently in human cancers, being overexpressed or activated in more than 70% of malignancies (1). It is a basic helix-loop-helix (bHLH) transcription factor that lies at the crossroads of many growth-promoting signal transduction and bioenergetic pathways (2). Genetic studies in animal models have revealed that suppression of Myc activation leads to rapid tumor shri...
متن کاملlnc RNAs, hypoxia and metastasis
In a variety of pathophysiological conditions oxygen demand exceeds its supply, leading to a compromising condition referred to as hypoxia, which triggers complex adaptive mechanisms mediated primarily through transcriptional reprogramming by hypoxia inducible factors (HIFs). Solid tumors are an example of this condition, as deregulated proliferation generates oxygen deficient microenvironments...
متن کاملAlternative regulation of MYC in lung cancer
Backman, Patrick N. M.S., Purdue University, May 2016. Alternative Regulation of MYC in Lung Cancer. Major Professor: Andrea Kasinski. Lung cancer is the leading cause of cancer deaths in the United States, accounting for 27% of all cancer induced deaths 1 . In an attempt to create a effective targeted therapy for the treatment of lung cancer, a strategy used to treat an activated Kras G12D/+ ;...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Research
سال: 2014
ISSN: 1001-0602,1748-7838
DOI: 10.1038/cr.2014.54